Christopher Richard Anzalone, Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 83,987 shares at $28.00 ($2.4M) on 2023-09-18, disclosed to the SEC on 2023-09-20.
Open-market sale of $2.4M ARWR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 31,523 | $883K | 37.3% |
| 2 | $28.27 | 26,232 | $742K | 31.3% |
| 3 | $28.27 | 26,232 | $742K | 31.3% |
| Total | $28.17 avg | 83,987 | $2.4M | 100% |
| Filing → |
| ARWR | SELL | 2025-12-23 | $3.5M | — | Filing → |
| ARWR | SELL | 2025-12-19 | $10.9M | — | Filing → |
| ARWR | SELL | 2025-12-16 | $24.6M | — | Filing → |